By Steve Johannsen : Protalix Biotherapeutics ( PLX ), partnered with Pfizer ( PFE ..... significant difference between the Protalix enzyme and their competitors ..... instead of mammal or yeast cells. Protalix completed a public offering on …
Canaccord takes some of the shine off Protalix 's ( PLX +13% ) early morning 27% run-up in the wake of the FDA's approval of its new treatment for Gaucher disease, downgrading …
… Scott Matusow : Yesterday after the Bell, Protalix ( PLX ) received approval from the FDA for its ..... 000 people in the U.S. Shares of PLX rallied as high as $7.80, up $0 ..... how IBIO uses a similar technology to PLX , but focuses its platform called "iBioLaunch …
… Breazzano : Patient investors in Protalix BioTherapeutics ( PLX ) were finally rewarded after ..... release that they approved Protalix 's new orphan drug (Elelyso ..... long and tortured ride for Protalix longs (and their partners …
Protalix BioTherapeutics ( PLX ) +22.8% AH after the FDA approves the company's new orphan drug to treat a form of Gaucher disease. Post your comment!
… get started in order to see what will take place this month. May 1st The FDA is scheduled to deliver Pfizer ( PFE ) and Protalix ( PLX ) a decision regarding the firms' Taliglucerase alfa. Taliglucerase is intended to treat patients with Gaucher disease …
… Vpriv is the second after Genzyme ( SNY ) to reach the market for Gaucher disease, and an important potential competitor to Protalix 's ( PLX ) taligucerase. Shire has received a Complete Response letter from the US Food and Drug Administration ("FDA") regarding …
… point for your analysis. Protalix BioTherapeutics Inc. ( PLX ) Drug Name: Taliglucerase ..... PDUFA; Date: May 1, 2012 Protalix is a biopharmaceutical company ..... expression system, ProCellEx. Protalix 's unique expression system …
… investors if the Company is financially well established. Protalix ( PLX ) has high chances to get approved considering the facts ..... 8th in San Diego, California. The FDA is already allowing Protalix and Pfizer ( PFE ) to treat Gaucher's patients under a compassionate …
… consultants that have been following Protalix ( PLX ) closely. We have discussed their ..... the upcoming approval decisions for Protalix 's Gaucher disease treatment (Taliglucerase Alfa). Protalix 's lead product candidate, Taliglucerase …